Get addiction help now: (858) 363-8214

get help now

Get addiction help now: (858) 363-8214

get help now

MARS Medicated Assisted Recovery Services Project

Time to read: 3 min

The peer facilitated Medication Assisted Recovery Services Project (MARS) is a collaboration between the National Alliance of Methadone Advocates (NAMA) and the Albert Einstein College of Medicine (AECOM), Division of Substance Abuse (DoSA). MARS is located in the Bronx, NY and will provide peer recovery support services to patients at AECOM’s Methadone Maintenance Treatment Programs.

 

The overall goal of MARS is to design, implement, and evaluate selected peer-delivered recovery support services that will complement the existing treatment program. The MARS project will provide persons whose recovery is assisted by medication.

 

MARS services include: training in medication assisted recovery, a mix of culturally appropriate support groups, drug and alcohol free social activities, recovery celebratory events, peer leader training and mentoring, and a peer council to help direct the development of the project.

 

The organized provision of peer recovery support services is completely new within medication assisted treatment (MAT), as is the collaboration of a peer-based recovery community organization (NAMA) with a major treatment provider (AECOM). How this collaboration evolves to deal with a population often neglected by the recovery community is key to the success of the project.

Grantee:

National Alliance of Methadone Advocates, Inc.
(Facilitating Organization)

Location:

Melrose On Track
260 East 161 Street
Bronx, New York 10451
718-993-3397

Contact(s):

Walter Ginter, CMA

Project Director
Vice President NAMA

Joycelyn Sue Woods, MA, CMA
Project Coordinator
President NAMA

MARS is a Recovery Community Support Program Grantee

Similar Posts

  • Accreditation, Advocacy and Patients in MAT

    ByAdmin
    Admin 10/31/2022

    James P. Connolly, CMA PA-NAMA and NAMA Newtown, PA Rebecca Ballard, CMA OK NAMA Tulsa, OK Carolyn Miranda, CMA NAMA SOCAL Fountain Valley, CA Changes in the service environment of MAT, expecially accreditation, are affecting relationships of patients, providers, and outside agencies. A panel of NAMA advocates will describe experiences with patient committees, staff advocacy…

  • Internet Resources

    ByAdmin
    Admin 05/29/2021

    Treatment Facility Locator Buprenorphine Physician Locator Maintenance Assistance Point (Europe) Indro’s Coordinating and Information Resource Center for International Travel Traveler’s Health Kit Office of National Drug Control Policy Center For Substance Abuse Treatment CSAT Patient Support & Community Education Project Program Version (PDF Format) National Clearinghouse Opioid Drugs in Maintenance and Detoxification Treatment of Opiate…

  • NAMA Education Series

    ByAdmin
    Admin 12/01/2021

    Number 1 Methadone Maintenance and Patient Self AdvocacyBy Arlene Ford (March, 1991). Number 2 Drug Policy in the Age of AIDS – The Philosophy of Harm ReductionBy Rod Sorge (April, 1991). Number 3 Myths About Methadone By Emmett Velten (March, 1992). Number 4 Methadone, HIV Infection, and Immune FunctionBy Herman Joseph (August, 1994). Number 5…

  • NAMA Organizational Meeting Monday, October 8th, 7 P.M.

    ByAdmin
    Admin 09/24/2022

    NAMA Organizational Meeting Monday, October 8th, 7 P.M. Chairs Jo Sotheran, NAMA Board of Directors (Treasurer) Joycelyn Woods, NAMA Board of Directors (President) As meeting starts Joycelyn Woods looks on over the shoulders of Tony Scro (NAMA Grievance Coordinator), James DePasquale (Long Island NAMA) and Donna Schoen (LIJ Patient Committee). Jo Sotheran introduces the reasons…

  • Patient “vs” Client

    ByAdmin
    Admin 12/04/2022

    Policy Statement Number 4 May 1994 Over the years methadone providers and patients have begun using client in place of patient. While this maybe well intended NAMA is concerned that the results could become damaging to methadone treatment, and most especially to patients. The use of client is deprogating to methadone patients, inferring that their…